A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age
PHASE3
The purpose of this study is to evaluate safety, tolerability and immunogen...
A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
PHASE2
The purpose of the study is to learn about the safety and effects of a comb...
Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older
PHASE1
The aim of this study is to evaluate the safety and immunogenicity of a hum...
Status
Active Not Recruiting
Location
Velocity Clinical Research, Phoenix- Site Number : 8400025